By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


aTyr Pharma Inc. 

10685 Road to the Cure
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-731-8389 Fax: 858-731-8394



Start Up

Company News
aTyr Pharma Announces Closing Of Initial Public Offering 5/13/2015 6:29:06 AM
aTyr Pharma Announces Pricing Of Initial Public Offering 5/7/2015 7:23:18 AM
aTyr Pharma Appoints Rare Disease Pioneer Mark Goldberg, M.D., To Board Of Directors 4/27/2015 7:39:11 AM
aTyr Pharma Receives U.S. FDA Orphan Designation For Resolaris 4/27/2015 6:28:51 AM
aTyr Pharma Appoints Marcy Graham As Vice President, Investor Relations And Corporate Communications 4/9/2015 6:41:19 AM
Rumors Prove True as SoCal's aTyr Pharma Files for $86 Million IPO 4/7/2015 6:02:31 AM
aTyr Pharma Secures $76 Million In Series E Financing 4/1/2015 8:10:37 AM
aTyr Pharma $76 Million Series E Gets IPO Rumors Flying 4/1/2015 8:06:54 AM
aTyr Pharma Inc. Receives European Medicines Agency Orphan Drug Designation For Resolaris In FSHD 2/18/2015 8:02:59 AM
aTyr Pharma Inc. Announces First FSHD Patient Study Of Resolaris™ 1/28/2015 7:20:52 AM